News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OncoGenex Pharmaceuticals Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013



8/9/2013 6:20:08 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOTHELL, Wash. and VANCOUVER, British Columbia, Aug. 8, 2013 /PRNewswire via COMTEX/ -- OncoGenex Pharmaceuticals, Inc. /quotes/zigman/111981/quotes/nls/ogxi OGXI +1.80% today provided an overview of clinical development activities for its two product candidates, custirsen and apatorsen (OGX-427), and announced second quarter 2013 financial results.

Hey, check out all the engineering jobs. Post your resume today!

Read at Market Watch

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES